S100A4 and amyotrophic lateral sclerosis: Since they display overt limitations, in further experiments patient-derived models, including iPSC-derived neurons and glia, as well as transdifferentiated somatic cells [35, 60], should be necessary to examine the specific role of S100A4 in the different ALS cell phenotypes.